Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 7/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | TAOK3 | Q9H2K8 | 3/20 | 0.38 |
| ▸ | TAOK1 | Q7L7X3 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3752863 | 0.75 | MTNR1A (0.64) | MTNR1AMTNR1BGRIN2BACHECA1 | |
| SCHEMBL3754299 | 0.74 | MTNR1A (0.56) | MTNR1AMTNR1BMAOAMAOBKMT2A | |
| SCHEMBL3219313 | 0.74 | MEN1 (0.52) | TAOK3TAOK1KMT2A | |
| SCHEMBL3219310 | 0.74 | MEN1 (0.52) | TAOK3TAOK1KMT2A | |
| SCHEMBL28684223 | 0.69 | MTNR1A (0.62) | MTNR1AMTNR1BMAOAMAOBPOLB | |
| SCHEMBL29433088 | 0.69 | MTNR1A (0.62) | MTNR1AMTNR1BMAOAMAOBPOLB | |
| SCHEMBL1970413 | 0.68 | MTNR1A (1.00) | MTNR1AMTNR1BMAOAMAOBGRIN2B | |
| SCHEMBL1970411 | 0.68 | MTNR1A (1.00) | MTNR1AMTNR1BMAOAMAOBGRIN2B | |
| SCHEMBL29565539 | 0.68 | MTNR1A (0.66) | MTNR1AMTNR1BMAOAMAOBKMT2A | |
| SCHEMBL3682479 | 0.68 | MTNR1A (0.66) | MTNR1AMTNR1BMAOAMAOBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298138-A1 | Aminoazoline and Urea Derivatives for Combating Animal Pests | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
| EP-2120576-A2 | AMINOAZOLINE AND UREA DERIVATIVES FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008145615-A2 | AMINOAZOLINE AND UREA DERIVATIVES FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298138-A1 | Aminoazoline and Urea Derivatives for Combating Animal Pests | AADAT, INMT, SLC14A1 | MTNR1A 3214/4885MTNR1B 2479/4885MAOA 1544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.